Decision

Early access to medicines scheme (EAMS) scientific opinion: Pembrolizumab (MK-3475)

This publication was withdrawn on

This scientific opinion has expired.

Information on the EAMS scientific opinion given to pembrolizumab (MK-3475), including the public assessment report.